AN2 THERAPEUTICS INC (ANTX): Ownership & Insider Activity

Hedge funds and institutional managers reporting a position in ANTX · Health Care. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.

Reported Holders
8
13F filers
Aggregate Value
$26.6M
Across holders
Last Price
$5.63
2026-08-24
Sector
Health Care
GICS
Quarterly fund activity5 increased2 reduced3 exited
Full exits: Hudson Bay Capital Management LP, MARSHALL WACE, LLP, Qube Research & Technologies Ltd
Institutional Holders of ANTX
8 holders
ManagerTypeSharesMarket Value% of Total% of PortfolioActionQoQ ChangeQuarter
MILLENNIUM MANAGEMENT LLC
CIK 0001273087
Hedge Fund2.32M$11.2M42.1%0.0%Added+$466KQ2 2026
ADAGE CAPITAL PARTNERS GP, L.L.C.
CIK 0001165408
Hedge Fund1.00M$4.8M18.2%0.0%Unchanged+$0Q2 2026
CITADEL ADVISORS LLC
CIK 0001423053
Hedge Fund952K$4.6M17.3%0.0%Added+$3.1MQ2 2026
BALYASNY ASSET MANAGEMENT LLC
CIK 0001218710
Hedge Fund556K$2.7M10.1%0.0%AddedQ2 2026
Woodline Partners LP
CIK 0001784547
Hedge Fund460K$2.2M8.4%0.0%Reduced$-2.6MQ2 2026
RENAISSANCE TECHNOLOGIES LLC
CIK 0001037389
Hedge Fund130K$628K2.4%0.0%Reduced$-334KQ2 2026
Walleye Capital LLC
CIK 0001758720
Hedge Fund72K$349K1.3%0.0%AddedQ2 2026
TWO SIGMA INVESTMENTS, LP
CIK 0001179392
Hedge Fund16K$77K0.3%0.0%AddedQ2 2026
Loading recent insider activity…